Response to Patoulias et al. letter regarding article “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial”
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | American Heart Journal |
Vol/bind | 236 |
Sider (fra-til) | 106 |
Antal sider | 1 |
ISSN | 0002-8703 |
DOI |
|
Status | Udgivet - 2021 |
ID: 302098131